Experimental mRNA vaccines gain steam with promising cancer trial results
Healthcare,Healthcare,Moderna,Merck,Big Pharma,Pharmaceuticals,Vaccines,Cancer
From the Left
AllSides Media Bias Rating: Lean Left
Pharmaceutical giants Moderna and Merck announced promising results from a clinical trial testing a combined treatment of an mRNA vaccine and immunotherapy for skin cancer. Melanoma patients who received monthly mRNA vaccines and Merck’s Keytruda immunotherapy had lower chances of cancer recurrence and spread, as well as higher survival rates, than those who received Keytruda alone.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
.jpg.webp)
